An IVF protocol is a carefully planned treatment schedule used during in vitro fertilization (IVF) to stimulate the ovaries, support the development of follicles and prepare for egg retrieval. There is no single IVF protocol that is suitable for every woman. The most appropriate approach is selected individually according to factors such as age, ovarian reserve, previous response to fertility treatment, medical history and the risk of ovarian hyperstimulation syndrome (OHSS).
During most IVF stimulation protocols, fertility medications are used to encourage several follicles to develop at the same time. The response of the ovaries is monitored with transvaginal ultrasound and, when necessary, hormonal blood tests. Medication doses and the timing of the different stages of treatment may be adjusted according to each woman’s response.
Different approaches are available, including the long GnRH agonist protocol, short protocol, GnRH antagonist protocol, mild ovarian stimulation and natural cycle IVF. Each has different characteristics, advantages and potential indications.
The goal is not simply to obtain the highest possible number of eggs, but to achieve an appropriate ovarian response while maintaining treatment safety and creating the best possible conditions for IVF. For this reason, the choice of protocol should always be personalized following a detailed fertility assessment.
What Is an IVF Protocol?
An IVF protocol is the individualized treatment plan followed during an in vitro fertilization cycle. It determines which medications are used, when treatment begins, how ovarian stimulation is monitored and when the final trigger injection and egg retrieval are scheduled.
In most IVF cycles, the ovaries are stimulated with gonadotropins to encourage the development of multiple follicles rather than the single follicle that usually develops during a natural menstrual cycle. Depending on the protocol, additional medications such as GnRH agonists or GnRH antagonists may be used to prevent premature ovulation and allow better control of the cycle.
Throughout ovarian stimulation, the development of the follicles is monitored mainly with transvaginal ultrasound and, when considered necessary, hormonal blood tests. The medication dose may be adjusted according to the ovarian response.
Once the follicles have reached an appropriate stage of development, a trigger injection is administered to support the final maturation of the eggs. Egg retrieval is then scheduled at the appropriate time.
The exact IVF protocol differs from one woman to another. The aim is to achieve a suitable ovarian response while maintaining safety and adapting treatment to the individual characteristics of each patient.
How Is the Right IVF Protocol Selected?
The choice of the most appropriate IVF protocol depends on the individual characteristics of each woman. Before treatment begins, the fertility specialist evaluates the patient’s medical and reproductive history in order to estimate how the ovaries are likely to respond to stimulation.
Important factors include age, ovarian reserve, AMH levels, antral follicle count (AFC), previous IVF attempts, response to fertility medications, body weight, PCOS and the risk of ovarian hyperstimulation syndrome (OHSS).
Women with a reduced ovarian reserve or a previous poor response may require a different stimulation strategy from women with a high ovarian reserve or polycystic ovaries. Similarly, previous IVF cycles can provide valuable information about the number of follicles developed, the number and maturity of the eggs retrieved and the overall response to medication.
The goal is to select a protocol that offers an appropriate ovarian response while reducing unnecessary medication and potential complications. For this reason, IVF treatment should not follow a one-size-fits-all approach.
A personalized protocol allows the fertility specialist to adjust the type and dose of medication, the duration of stimulation and the timing of the trigger injection according to the patient’s response throughout the cycle.
1. Long GnRH Agonist Protocol
The long GnRH agonist protocol usually begins during the luteal phase of the menstrual cycle before ovarian stimulation. A GnRH agonist is administered to temporarily suppress the natural hormonal activity of the ovaries and prevent premature ovulation. Once down-regulation has been achieved, daily gonadotropin injections are started to stimulate the development of multiple follicles. Follicular growth is monitored with transvaginal ultrasound and, when necessary, hormonal blood tests. When the follicles have reached an appropriate stage of development, a trigger injection is administered for final oocyte maturation and egg retrieval is subsequently scheduled. The long protocol may be considered in selected patients depending on their ovarian reserve, medical history and previous response to IVF treatment.
2. Short or Flare IVF Protocol
The short GnRH agonist protocol, also known as the flare protocol, begins during the first days of the menstrual cycle. A GnRH agonist is introduced early in the cycle and gonadotropin injections are subsequently added to stimulate follicular development. Unlike the long protocol, there is no prolonged period of ovarian suppression before stimulation, resulting in a shorter overall treatment duration. The ovarian response is monitored throughout the cycle and the timing of the trigger injection and egg retrieval is determined according to follicular development. This protocol may be considered in selected patients based on their ovarian reserve, age and response to previous stimulation cycles.
3. GnRH Antagonist Protocol
In the GnRH antagonist protocol, ovarian stimulation with gonadotropins usually begins during the first days of the menstrual cycle. A GnRH antagonist is added later during stimulation to prevent a premature LH surge and premature ovulation while the follicles continue to develop. Regular ultrasound monitoring, with hormonal blood tests when indicated, allows the fertility specialist to assess follicular growth and adjust treatment when necessary. Once the follicles are appropriately developed, a trigger injection is administered and egg retrieval follows. GnRH antagonist protocols are widely used in IVF and are particularly useful when reducing the risk of ovarian hyperstimulation syndrome (OHSS) is an important consideration.
4. Mild IVF Stimulation with Clomiphene or Letrozole
Mild or minimal IVF stimulation uses a less intensive approach to ovarian stimulation and may combine oral medications such as clomiphene citrate or letrozole with lower or individualized doses of gonadotropins. Treatment usually begins early in the menstrual cycle, while follicular development is monitored with ultrasound and additional hormonal testing when required. Depending on the stimulation strategy, a GnRH antagonist may also be introduced to prevent premature ovulation. Once suitable follicular development has been achieved, final oocyte maturation is triggered and egg retrieval is scheduled. Mild stimulation may be considered for selected women depending on ovarian reserve, previous IVF response and the overall treatment strategy.
5. Natural Cycle IVF
In natural cycle IVF, little or no ovarian stimulation medication is used, with the aim of retrieving the egg that develops naturally during the menstrual cycle. Follicular growth is closely monitored with transvaginal ultrasound and, when necessary, hormonal blood tests so that ovulation and egg retrieval can be timed appropriately. Because usually only one dominant follicle develops, the number of eggs available for fertilization is limited compared with conventional ovarian stimulation. Natural or modified natural cycle IVF may be considered in selected women, including some patients with a very low ovarian reserve or those for whom conventional stimulation is not considered appropriate. However, it is not routinely recommended as a better alternative to conventional stimulation for all low responders, and the decision should be individualized according to ovarian reserve, age, previous treatment history and reproductive goals.
Monitoring During an IVF Stimulation Protocol
Careful monitoring is an important part of every IVF stimulation protocol, as it allows the fertility specialist to assess how the ovaries are responding to treatment and determine the appropriate timing for the final trigger. Monitoring is performed primarily with transvaginal ultrasound, which measures the number and size of developing follicles. Hormonal blood tests may also be requested in selected cases, although routine addition of estradiol or a full hormonal panel to ultrasound monitoring is not considered necessary for every patient. Based on follicular development and the individual ovarian response, medication doses or treatment timing may be adjusted. Once the follicles have reached an appropriate stage of development, the fertility specialist determines when final oocyte maturation should be triggered and when egg retrieval should take place.
Trigger Injection and Egg Retrieval
When the developing follicles have reached an appropriate stage, a trigger injection is administered to promote the final maturation of the oocytes before egg retrieval. Depending on the IVF protocol and the woman’s individual response, final oocyte maturation may be triggered with hCG, a GnRH agonist or another individualized strategy. In women at increased risk of ovarian hyperstimulation syndrome (OHSS), a GnRH agonist trigger may be preferred within an antagonist protocol as part of a strategy to reduce this risk. Egg retrieval is then scheduled at the appropriate interval after the trigger and is usually performed transvaginally under ultrasound guidance with sedation or analgesia. During the procedure, follicular fluid is aspirated from the ovaries and the retrieved oocytes are transferred to the embryology laboratory for assessment and subsequent fertilization.
Which IVF Protocol Is Best?
There is no single IVF protocol that is best for every woman. The most appropriate approach depends on individual factors such as ovarian reserve, previous response to stimulation, medical history and the risk of complications such as ovarian hyperstimulation syndrome (OHSS). Tests such as AMH and antral follicle count (AFC) can help predict whether a woman is likely to have a high or low response to ovarian stimulation, while previous IVF cycles can also provide valuable information for treatment planning.
For some patients, a GnRH antagonist protocol may offer greater flexibility and a lower risk of OHSS, while others may benefit from a long agonist, short, mild stimulation or natural cycle approach. The objective is not simply to retrieve the greatest possible number of eggs, but to achieve an appropriate ovarian response while maintaining treatment safety. For this reason, the choice of IVF protocol should always be individualized after a complete fertility assessment.
Personalized IVF Protocols
The choice of an IVF protocol should always be personalized according to the individual characteristics and reproductive history of each patient. Dr. Panagiotis Kaliantzis evaluates factors such as age, ovarian reserve, AMH and antral follicle count, previous IVF attempts, response to ovarian stimulation and overall medical history before recommending the most appropriate treatment strategy.
Throughout the IVF cycle, ovarian response is monitored carefully so that medication doses and treatment timing can be adjusted when necessary. Whether the selected approach involves a GnRH antagonist protocol, long or short agonist protocol, mild stimulation or natural cycle IVF, the aim is to achieve an appropriate response while prioritizing safety and individualized care.
Patients considering IVF can receive a complete fertility assessment and a personalized treatment plan at the clinics in Athens and Tripoli, with each stage of treatment adapted to their specific needs and reproductive goals.
Frequently Asked Questions About IVF Protocols
Which IVF protocol is most commonly used?
The GnRH antagonist protocol is widely used in modern IVF because it offers a shorter treatment duration and allows greater flexibility in controlling ovarian stimulation. It can also help reduce the risk of ovarian hyperstimulation syndrome (OHSS) in patients who are more likely to have a high ovarian response.
How long does an IVF stimulation protocol take?
The duration depends on the type of protocol and the individual ovarian response. In many IVF cycles, ovarian stimulation lasts approximately 8–14 days, while a long GnRH agonist protocol involves an additional period of down-regulation before stimulation begins.
What is the difference between a long and short IVF protocol?
The long IVF protocol involves ovarian suppression with a GnRH agonist before gonadotropin stimulation begins. In the short or flare protocol, treatment starts during the first days of the menstrual cycle without a prolonged down-regulation phase, resulting in a shorter overall treatment schedule.
Which IVF protocol is used for low AMH or poor ovarian response?
There is no single protocol that is appropriate for every woman with low AMH or poor ovarian response. AMH and antral follicle count (AFC) can help predict the expected ovarian response, while previous IVF cycles and the patient’s individual fertility history are also considered when planning treatment.
Can IVF be performed without ovarian stimulation?
Yes. Natural cycle IVF aims to retrieve the egg that develops naturally during the menstrual cycle, using little or no ovarian stimulation medication. However, because usually only one dominant follicle develops, fewer eggs are available compared with conventional stimulated IVF.
Can an IVF protocol be changed during treatment?
Certain aspects of treatment may be adjusted according to the ovarian response observed during monitoring. The fertility specialist may modify medication doses or treatment timing when clinically appropriate, while decisions regarding the trigger injection are also individualized according to follicular development and patient safety.
